EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions

Yuliya Semenova iD, Zhandos Burkitbayev, Nurtas Kalibekov, Alexandr Digay, Bakhyt Zhaxybayev, Oxana Shatkovskaya, Saule Khamzina iD, Dinara Zharlyganova, Zhuldyz Kuanysh, Almira Manatova

Cancers · 25.06.2025 · 17 (13) · 2143

DOI: 10.3390/cancers17132143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.06.2025. Verfasst von Yuliya Semenova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science and Higher Education of the Republic of Ka-zakhstan, Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pleural malignancies represent a clinically devastating group of oncological disorders, most commonly arising from metastatic disease, with lung and breast cancers being the most frequent primary sites. Malignant pleural mesothelioma is a primary malignancy of the pleura and occurs less often than metastatic pleural disease. Pleural malignancies often present with malignant pleural effusion, which typically indicates advanced-stage disease and is associated with poor overall prognosis. Treatment of pleural malignancies includes both palliative and definitive approaches. Palliative interventions primarily aim to relieve symptoms and improve quality of life. Definitive treatments include systemic chemotherapy, targeted therapy, and immunotherapy, depending on the type and molecular profile of the underlying tumor. In mesothelioma, platinum-based chemotherapy in combination with pemetrexed remains the cornerstone of treatment, while the combination of nivolumab and ipilimumab is recommended as first-line therapy for unresectable disease. For metastatic disease, systemic therapy is typically tailored to the primary tumor’s characteristics. Intrapleural administration of chemotherapeutic agents is one of the therapeutic strategies and hyperthermic intrathoracic chemotherapy and pressurized intrathoracic aerosol chemotherapy are the most recent innovations that are under active investigation. This review provides an up-to-date synthesis of systemic chemotherapy strategies for pleural malignancies, their integration with targeted and immune-based therapies, and recent advances in intrapleural chemotherapy modalities. It also explores existing knowledge gaps and outlines directions for future research and potential changes in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

chemotherapyhyperthermic intrathoracic chemotherapyimmunotherapymalignant pleural effusionmalignant pleural mesotheliomapleural metastasespressurized intrathoracic aerosol chemotherapytargeted therapy

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
  • Chairman of the board, National Research Oncology Center, Astana 020000, Kazakhstan.
  • Department of Multidisciplinary Surgery, National Research Oncology Center, Astana 020000, Kazakhstan.
  • Vice-Chairman of the board for Strategic Development, Scientific and Educational Activities, National Research Oncology Center, Astana 020000, Kazakhstan.
  • Department of Scientific Management, National Research Oncology Center, Astana 020000, Kazakhstan.

ORCID-Profile: Yuliya Semenova, Saule Khamzina

Förderung

  • Committee of Science of the Ministry of Science and Higher Education of the Republic of Ka-zakhstan
  • Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Semenova, Y., Burkitbayev, Z., Kalibekov, N., Digay, A., Zhaxybayev, B., Shatkovskaya, O., Khamzina, S., Zharlyganova, D., Kuanysh, Z., & Manatova, A. (2025). The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions. Cancers, 17(13), 2143. https://doi.org/10.3390/cancers17132143

Vancouver

Semenova Y, Burkitbayev Z, Kalibekov N, Digay A, Zhaxybayev B, Shatkovskaya O, et al. The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions. Cancers. 2025;17(13):2143. doi:10.3390/cancers17132143

BibTeX
@article{Semenova2025,
  author = {Semenova, Yuliya and Burkitbayev, Zhandos and Kalibekov, Nurtas and Digay, Alexandr and Zhaxybayev, Bakhyt and Shatkovskaya, Oxana and Khamzina, Saule and Zharlyganova, Dinara and Kuanysh, Zhuldyz and Manatova, Almira},
  title = {The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2143},
  doi = {10.3390/cancers17132143}
}
Kostenlos starten →